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Operating in the Dark: A Night-Vision System for Surgery in Retinas Susceptible
to Light Damage
Abstract
A standard operating microscope was modified with a bandpass infrared filter in the light path and
infrared image intensifiers for each of the 2 eyepieces. We evaluated this system for subretinal injections
in normal control dogs and those with a mutation in the rhodopsin gene. Rhodopsin-mutant dogs are a
model for human autosomal dominant retinitis pigmentosa, and their retinas degenerate faster when
exposed to modest light levels as used in routine clinical examinations. We showed that the mutant
retinas developed severe generalized degeneration when exposed to the standard operating microscope
light but not the infrared light. The modified operating microscope provided an excellent view of the
ocular fundus under infrared illumination and allowed us to perform subretinal injections in the retinas of
the rhodopsin-mutant dogs without any subsequent light-induced retinal degeneration.
The first description of light-induced retinal damage showed that exposure of albino rats to visible light
intensities ordinarily encountered in the laboratory led to irreversible retinal damage.1 This finding soon
was extended to other species, including rabbits2 and monkeys.3 Studies in animal models of retinal
degeneration (eg, Royal College of Surgeons rats, ABCA4-mutant mice, or rhodopsin-mutant mice and
dogs) have emphasized the interplay between the gene mutation and environmental light and
demonstrated acceleration of the disease process by light.4- 10 The effect of environmental light on
disease severity in humans with retinitis pigmentosa has been suggested by case reports,11 although
definitive proof is lacking. However, patients with class B1 rhodopsin mutations may be at risk of
accelerated vision loss with increased light exposures because they have defects in dark (bleaching)
adaptation similar to those found in rhodopsin-mutant dogs that demonstrate a high susceptibility to
retinal light damage.8,12,13
Many of the emerging therapies for retinal degeneration require the intraocular placement of a reagent or
device with the use of an operating microscope.14,15 The damaging effect of the microscope light on the
normal retina, even with the appropriate filtering of UV light, has been described previously,16,17 and there
is increased emphasis on reducing the intensity and duration of the exposures. Herein, we describe a
modification of an operating microscope with an infrared bandpass filter and a night-vision system to
perform surgical interventions in the posterior segment of the eyes of rhodopsin-mutant dogs without the
risk of photochemical retinal damage. This modification prevents acceleration of the photoreceptor
degeneration that occurs with exposure to modest light levels as used in routine clinical practice.8 If
humans with retinitis pigmentosa are shown to have similar light damage susceptibility, this microscope
modification could be considered for surgical procedures such as the subretinal application of gene
therapy vectors.
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Abstract
A standard Zeiss OPMI 6 operating microscope was modified with a bandpass infrared filter in the
light path, and infrared image intensifiers for each of the two eye pieces. The aim of the study was
to evaluate this system for subretinal injections in normal control and rhodopsin mutant dogs. These
dogs are a model for human autosomal dominant retinitis pigmentosa (adRP), and their retinas
degenerate faster when exposed to modest light levels as used in routine clinical examinations. We
showed that the mutant retinas developed severe generalized degeneration when exposed to the
standard operating microscope light, but not the infrared light. The modified operating microscope
provided excellent view of the ocular fundus under infrared illumination, and allowed us to perform
subretinal injections in the rhodopsin mutant dog retinas without any subsequent light-induced retinal
degeneration.

INTRODUCTION
The first description of light-induced retinal damage showed that exposure of albino rats to
visible light intensities ordinarily encountered in the laboratory led to irreversible retinal
damage.1 This finding soon was extended to other species including rabbits2 and monkeys.3
Studies in animal models of retinal degeneration, e.g. RCS rats, ABCA4 mutant mice, or
rhodopsin mutant mice and dogs, have emphasized the interplay between the gene mutation
and environmental light, and demonstrated acceleration of the disease process by light.4–10
The effect of environmental light on disease severity in human patients with retinitis
pigmentosa (RP) has been suggested by case reports,11 although definitive proof is lacking.
However, patients with Class B1 rhodopsin mutations may be at risk for accelerated vision
loss with increased light exposures as they have similar defects in dark (bleaching) adaptation
as rhodopsin mutant dogs that demonstrate a high susceptibility to retinal light damage.8,12,
13
Many of the emerging therapies for retinal degenerations require the intraocular placement of
a reagent or device using an operating microscope.14,15 The damaging effect of the
microscope light on the normal retina, even with the appropriate filtering of ultraviolet light,
has been described,16,17 and there is increased emphasis in reducing both the intensity and
duration of the exposures. Herein, we describe a modification of an operating microscope with
an infrared bandpass filter and a night vision system to carry out surgical interventions in the
posterior segment of the eyes of rhodopsin mutant dogs without the risk of photochemical
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retinal damage. This modification prevents acceleration of the photoreceptor degeneration that
occurs with exposure to modest light levels as used in routine clinical practice.8 If human
patients are shown to have similar light damage susceptibility, this microscope modification
could be considered for surgical procedures such as the subretinal application of gene therapy
vectors.

METHODS
A Zeiss OPMI 6 operating microscope equipped with a standard, manufacturer-provided 100W tungsten halogen low voltage lamp (HLX 64627; Osram Sylvania, Danvers, MA) and 475nm long pass filter (GG475; Schott, Mainz, Germany) was used for the subretinal injection
studies. For the surgeries under dark conditions, an infrared bandpass filter (RT-830; Hoya
Corporation USA, San Jose, CA) with a central wavelength of 830 nm and a full width at half
maximum of 260 nm was placed in the microscope’s light path using an already existing slider
on the OPMI 6 (Figure 1). Monocular infrared image intensifiers were attached to each of the
two eyepieces with custom-built adapters for the Zeiss OPMI 6 microscope (Owl Nitemare
3rd Generation; B.E. Meyers & Co, Inc., Redmond, WA); the infrared image intensifiers had
a resolution of 56 line pairs per millimeter (Figure 1).
Bilateral subretinal injections of saline were performed in normal control and rhodopsin mutant
dogs. We recently identified this naturally occurring canine model of autosomal dominant RP
(adRP), and determined the cause to be a T4R missense mutation in the rhodopsin gene.8,13
For this study, the dogs were kept under the same standard light conditions that they were
exposed to since birth, i.e. 12 hours on / 12 hours off light/dark cycles with an irradiance during
the light phase between 0.003 and 0.015 mW/cm2; the irradiance range depended on the dog’s
location in the kennel. These environmental light conditions were used because they do not
cause retinal degeneration within the first year of life in this model provided no ophthalmic
examination procedures are performed.8 All procedures were done in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
One eye of each dog was injected under standard light conditions while the contralateral eye
was injected under dark conditions with the infrared bandpass filter and infrared image
intensifiers. While one eye was operated, the fellow eye was covered with a black, nontransparent plastic occluder. Our protocol for subretinal injections in dogs has previously been
described.18 The induction of general anesthesia and the preparation of the eyes were done
under regular ambient room lights (irradiance = 0.14 mW/cm2).a As soon as the operating
microscope with its light source was brought into position, the overhead room lights were
turned off, and only a red darkroom safelight (Kodak 1A filter) was kept on in a distant corner
of the room. As a reference, the irradiance measured at the plane of the cornea was 36 mW/
cm2 with the standard microscope light, and 6.1 mW/cm2 when the infrared bandpass filter
was used (in both cases brightness setting #5 on the OPMI 6). In terms of illuminance, these
irradiances represent 6,670 lux without filter, and 0.18 lux with the infrared bandpass filter.
For the subretinal injections, a Chalam Direct Flat SSV® surgical lens (Volk; Mentor, OH)
was placed on the cornea for visualization of the ocular fundus. The globe was penetrated with
the 25-G needle of a RetinaJect™ subretinal injection device (SurModics, Inc., Eden Prairie,
MN18) 6 mm posterior to the limbus, and the tip of the needle was brought into proximity of
the retinal surface. Next, a 39-G cannula was extended from the tip of the 25-G needle and
brought tangentially into contact with the retina, followed by the rapid injection of 150 µl of
saline. Successful injection was recognized by the formation of a subretinal bleb in the area

aThe ambient light intensities in this report were slightly higher than ambient light measured in a vitreoretinal surgery suite in a human
medical center (0.07 mW/cm2).
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centralis region of the fundus which is comparable to the human macular region. The total time
period during which the eyes were exposed to the microscope light was between 8–10 minutes,
and was comparable for both standard and infrared illumination surgical procedures.
In order to demonstrate the effect of a range of light intensities, that may be used for surgical
procedures other than subretinal injections, the anterior and posterior ocular segments of
anesthetized rhodopsin mutant dogs were visualized for 10 minutes with the OPMI6 using
irradiances between 0.74 and 17.6 mW/cm2 (brightness settings between #3.5 and #4.5 on the
OPMI 6) without performing surgery.
Following surgery or light exposure procedures, the dogs were kept for 15 days under the same
light conditions as prior to surgery. No additional ophthalmic procedures were used to monitor
the rhodopsin mutant dogs in order to prevent retinal damage unrelated to the surgery. After
15 days, the dogs were euthanatized and the eyes were fixed in Bouin’s solution for routine
processing and embedding in paraffin. Globes were oriented so that sections were made through
the center of the subretinal injection sites. The tissue sections were stained with hematoxylin
and eosin (H&E).

RESULTS
The combination of the infrared bandpass filter and the infrared image intensifiers provided
good illumination and sufficient resolution to perform subretinal injections. The estimated
maximal resolution decreased from ~10 µm with the standard light condition to ~20 µm with
the use of the infrared image intensifiers; this small loss in resolution did not affect the surgical
performance. The main difference to the standard illumination was that the image provided by
the night vision system appeared in shades of green rather than in colors. This did not create a
challenge as the available illumination and resolution allowed the visualization of important
anatomic structures and landmarks.
Morphologic assessment of the normal control retinas showed that the injected and noninjected areas were normal for both the standard and infrared light conditions (data not shown).
In contrast, the rhodopsin mutant retinas operated under standard light conditions were severely
and uniformly degenerate in both injected and non-injected areas. There was complete loss of
photoreceptors, almost unrecognizable outer nuclear layers, and loss of many retinal pigment
epithelial (RPE) cells (Figures 2A – 2D). There were no obvious differences in the degree of
retinal degeneration between the tapetal (RPE not pigmented, Figures 2A & 2B) and the nontapetal regions (RPE pigmented, Figures 2C & 2D). The retinas that were injected using the
infrared night vision system and infrared light were normal both inside (Figures 2E & 2F) and
outside (data not shown) the subretinal injection sites.
All the light settings that were evaluated on the OPMI6 (#3.5 – 5) lead to the same severe
degeneration of the rhodopsin mutant retinas. The same damage was found with and without
the use of a surgical lens. Differences between the brightness settings were seen in the size of
the estimated areas of photoreceptor loss (~37% for setting #3.5, ~51% for setting #4, and
100% for settings #4.5 and #5) with the central retinas always being most severely affected.
We compared these brightness settings with a more current operating microscope model, the
Zeiss VISU160, that uses the same tungsten halogen low voltage lamp (Figure 3). The
irradiance values for the VISU160 brightness settings commonly used by cataract surgeons
(settings #0.3 – 0.6) are within the irradiances evaluated in this study which caused light
induced retinal degeneration.
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COMMENT
The potential contribution of environmental light to the modification of inherited retinal
degenerations in humans has been suggested,11 and supported by more recent experimental
studies in several animal models of retinal degeneration.4–10 We now show that even a short
ophthalmic surgical procedure lasting less than 10 minutes and using the standard 475-nm long
pass filter (GG 475) provided by the manufacturer with the Zeiss OPMI 6 results in severe
degeneration of the rhodopsin mutant canine retina.
These results confirm our previous work showing a very rapid retinal degeneration in the
rhodopsin mutant dog retinas following clinical light exposures such as used in routine fundus
photography.8 In contrast to the rather localized damage found with fundus photography,
however, the standard lights of the operating microscope caused wide-field degeneration
extending beyond the subretinal injection site. This could result from the wider distribution of
the incident light on the retina by the surgical lens and/or the longer exposure times (minutes
vs. microseconds). A similar susceptibility to light damage during ophthalmic procedures has
been identified in the T17M rhodopsin transgenic mouse.10 The T4R and T17M mutations in
dogs and mice, respectively, alter the first and second opsin consensus glycosylation sites,19
and possibly render the mutant protein-chromophore combination exquisitively susceptible to
damage from low levels of light exposure.
Previous reports, and the manufacturer’s specifications, state that the infrared output represents
a significant portion of the total irradiation produced by the tungsten halogen lamp.20 We took
advantage of this infrared irradiation by placing an infrared bandpass filter in the operating
microscope light path; this reduced the irradiance by a factor of ~6, and the illuminance by a
factor of ~37,000, and prevented the light-associated degeneration of the rhodopsin mutant
retina. By almost completely eliminating light within and below the visual pigment absorption
spectrum, we prevented the risk of photochemical retinal damage.21
The use of a night vision system allowed the proper visualization of the surgical field, including
the fundus, to successfully perform subretinal injections. Although the minimal loss of
resolution did not affect the surgical performance, infrared image intensifiers with higher
resolution of up to 72 line pairs per millimeter (instead of the 56 line pairs per millimeter used
in this study) are currently available and could be considered for use. Recently, a similarly
modified near-infrared Zeiss operating microscope with head-mounted displays was presented
for lightless cataract surgery.22 The author’s purpose was to prevent light-associated
complications of cataract surgery, i.e. photochemical retinal damage.22 That system could be
equally applicable for surgical manipulations in patients with retinal diseases that would render
them susceptible to light damage.
Many of the newly emerging treatment options for retinal degenerations require surgical
interventions that utilize an operating microscope. In experimental animals with increased
susceptibility to retinal light damage,8,10 and possibly in human patients with homologous
disorders,12 minimizing light exposures during retinal or other ophthalmic surgical procedures
may be necessary. The modification of a standard operating microscope with infrared bandpass
filters and infrared night vision system provides an approach to make such surgical procedures
safer in those human patients where the disease phenotype may be modified by light exposures
used in routine clinical practice.
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Figure 1.

The Zeiss OPMI 6 operating microscope modified with the monocular Owl Nitemare night
vision systems. The arrow points to the location of the slider housing the infrared bandpass
filter.
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Figure 2.

Photomicrographs showing rhodopsin mutant canine retinas 15 days after subretinal injection
of saline. With the use of the standard operating microscope light, the retinas showed extensive
outer retinal and RPE degeneration in both the injected (A, B) and non-injected areas (C, D)
of different dogs. With the use of the night vision system and infrared light in the fellow eyes,
the retinal morphology remained normal in the injected areas (E, F). Hematoxylin and eosin
stain; calibration marker=50 µm.
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Figure 3.

Comparison of brightness settings between the Zeiss OPMI6 and VISU160 operating
microscopes. The gray area shows the range of commonly used VISU160 settings (0.3 – 0.6)
that were overlapped with the OPMI6 settings evaluated in this study (3.5 – 5).
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